Article ID Journal Published Year Pages File Type
8766029 Porto Biomedical Journal 2017 5 Pages PDF
Abstract
Rituximab is a clinical effective treatment for B cell-related diseases like MG and seems to be a cost-saving intervention. Its use is associated with a decrease in the need for other immunosuppressive treatments whilst improving quality of life and reducing health costs.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Preview
Rituximab in generalized myasthenia gravis: Clinical, quality of life and cost-utility analysis
Authors
, , , ,